A proposal for radical changes in the drug-approval process
- PMID: 16899784
- DOI: 10.1056/NEJMsb055203
A proposal for radical changes in the drug-approval process
Erratum in
- N Engl J Med. 2006 Dec 21;355(25):2712
Comment in
-
A new approach to drug development.N Engl J Med. 2006 Nov 9;355(19):2045; author reply 2046. doi: 10.1056/NEJMc062426. N Engl J Med. 2006. PMID: 17093258 No abstract available.
-
A new approach to drug development.N Engl J Med. 2006 Nov 9;355(19):2046; author reply 2046. N Engl J Med. 2006. PMID: 17099947 No abstract available.
-
A new approach to drug development.N Engl J Med. 2006 Nov 9;355(19):2045; author reply 2046. N Engl J Med. 2006. PMID: 17099948 No abstract available.
-
A new approach to drug development.N Engl J Med. 2006 Nov 9;355(19):2045; author reply 2046. N Engl J Med. 2006. PMID: 17099949 No abstract available.
Similar articles
-
[FDA's new drug approval system].Gan To Kagaku Ryoho. 1995 Aug;22(9):1146-51. Gan To Kagaku Ryoho. 1995. PMID: 7661565 Review. Japanese. No abstract available.
-
Drug safety on trial.Nature. 2005 Mar 31;434(7033):545. doi: 10.1038/434545a. Nature. 2005. PMID: 15800579 No abstract available.
-
Drug safety special: the safety catch.Nature. 2005 Mar 31;434(7033):554-6. doi: 10.1038/434554a. Nature. 2005. PMID: 15800591 No abstract available.
-
Improving how we evaluate the toxicity of approved drugs.Clin Pharmacol Ther. 2006 Jul;80(1):1-6. doi: 10.1016/j.clpt.2006.03.006. Epub 2006 Jun 8. Clin Pharmacol Ther. 2006. PMID: 16815311 Review. No abstract available.
-
Dermatology clinical trials and drug development.Dermatol Nurs. 2003 Oct;15(5):428-34. Dermatol Nurs. 2003. PMID: 14619320 Review. No abstract available.
Cited by
-
Response to AMA's Council on Ethical and Judicial Affairs draft report on "Ethical guidance for physicians and the profession with respect to industry support for professional education in medicine".Medscape J Med. 2008 Jun 12;10(6):137. Medscape J Med. 2008. PMID: 18679553 Free PMC article. No abstract available.
-
Economic evaluations in the canadian common drug review.Pharmacoeconomics. 2006;24(11):1157-62. doi: 10.2165/00019053-200624110-00011. Pharmacoeconomics. 2006. PMID: 17067199 Review.
-
Gap in publication of comparative information on new medicines.Br J Clin Pharmacol. 2008 May;65(5):716-22. doi: 10.1111/j.1365-2125.2007.03092.x. Epub 2008 Feb 21. Br J Clin Pharmacol. 2008. PMID: 18294324 Free PMC article. Review.
-
Drug discovery in jeopardy.J Clin Invest. 2006 Nov;116(11):2837-42. doi: 10.1172/JCI29999. J Clin Invest. 2006. PMID: 17080187 Free PMC article.
-
Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance.Ther Adv Psychopharmacol. 2013 Aug;3(4):233-43. doi: 10.1177/2045125312472530. Ther Adv Psychopharmacol. 2013. PMID: 24167695 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources